We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand your risk of ovarian cancer after a hysterectomy. Learn about symptoms, diagnosis, treatment, and prevention strategies.
A hysterectomy is a significant surgery, and it's understandable to wonder about its long-term effects on your health. Many women who have had their uterus removed assume that certain cancer risks, like ovarian cancer, are completely eliminated. While a hysterectomy does reduce the risk of ovarian cancer, it doesn't always eliminate it entirely. This is a critical piece of information for women to understand, especially when discussing their overall health and cancer screening with their doctors.
Let's clarify what a hysterectomy involves and how it impacts your risk for ovarian cancer. A hysterectomy is the surgical removal of the uterus. There are different types of hysterectomies:
The key factor in understanding ovarian cancer risk after hysterectomy lies in whether your ovaries were removed during the procedure. In many hysterectomy procedures, the ovaries are left in place. While removing the uterus lowers your risk of developing ovarian cancer by about one-third, leaving the ovaries means the risk, though reduced, is still present.
Even if your ovaries were removed during a hysterectomy (a BSO), there's a small possibility of developing ovarian cancer. How can this happen? Ovarian cells can sometimes migrate. Before the ovaries are removed, some ovarian cells might spread to other areas, particularly the peritoneum, which is the lining of your abdominal cavity. If these cells remain after the ovaries are gone and later become cancerous, it is still considered ovarian cancer, even though the original ovaries are no longer present.
Additionally, cancer can sometimes develop from cells in the peritoneum itself. While technically not ovarian cancer, peritoneal cancer behaves very similarly to ovarian cancer and is treated with the same methods. This is often referred to as primary peritoneal cancer.
A Real-Life Scenario: Imagine Mrs. Sharma, who had a total hysterectomy five years ago due to fibroids. Her ovaries were left in place. Recently, she experienced persistent bloating and abdominal discomfort. Her doctor, aware of her hysterectomy history, ordered further tests, including a CA-125 blood test and a transvaginal ultrasound, which revealed concerning findings suggestive of ovarian cancer. This highlights that even with a hysterectomy, vigilance is necessary.
Ovarian cancer originates from the cells of the ovaries. The ovaries are vital organs responsible for producing eggs and secreting essential female hormones like estrogen and progesterone. Most ovarian cancers begin in the epithelial cells, which form the outer surface of the ovary. However, cancer can also arise from germ cells (which produce eggs) or stromal cells (which produce hormones).
It's important to remember that ovarian cancer is relatively rare. The lifetime risk for women in India is estimated to be around 1.25 percent. However, this risk can increase significantly for individuals with certain genetic mutations, such as BRCA1 and BRCA2. For women with these mutations, the risk of developing ovarian cancer by age 70 can be as high as 30 percent or more.
Because ovarian cancer is often diagnosed at later stages, recognizing its symptoms is paramount. Many of these symptoms can be subtle and easily mistaken for other common conditions, especially in women who have had a hysterectomy. Be aware of:
If you experience any of these symptoms persistently, it's vital to consult your doctor promptly, regardless of whether you've had a hysterectomy.
Diagnosing ovarian cancer, especially after a hysterectomy, requires a thorough evaluation. Doctors may:
Treatment for ovarian cancer depends on the stage, type, and your overall health. Common treatments include:
While not all ovarian cancer is preventable, certain measures can significantly reduce your risk:
You should consult your doctor immediately if you experience any persistent symptoms suggestive of ovarian cancer, especially if you have risk factors such as a family history of the disease or specific genetic mutations. Even after a hysterectomy, regular gynecological check-ups are important. If you have had a hysterectomy and are concerned about your ovarian cancer risk, have an open conversation with your healthcare provider. They can assess your individual risk factors and recommend appropriate screening or monitoring strategies.
While removing the ovaries significantly lowers your risk, there's still a very small chance of developing cancer from residual ovarian cells that may have migrated to the peritoneum before the surgery, or from peritoneal cells themselves (primary peritoneal cancer). It's much rarer than developing ovarian cancer when ovaries are present.
Ovarian cancer starts in the ovary itself. Primary peritoneal cancer starts in the peritoneum, the lining of the abdominal cavity. They share many similarities in symptoms, treatment, and prognosis, and are often treated similarly, especially if ovaries have been removed.
The CA-125 test can be a useful tool, but it's not definitive. CA-125 levels can be elevated in other non-cancerous conditions like endometriosis, fibroids, or infections. It's best used in conjunction with other diagnostic methods and clinical evaluation by your doctor.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026